Palvella Therapeutics

About:

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Top Investors: Adams Street Partners, BioAdvance, Samsara BioCapital, Ligand Pharmaceuticals, Biotechnology Value Fund

Description:

Palvella Therapeutics is a start-up life sciences company that focuses on relentlessly and selflessly serving abandoned patient populations with therapies. The company specializes in developing therapies that specifically target the root cause of the disease. Palvella Therapeutics was founded in 2015 and headquartered in Wayne, Pennsylvania.

Total Funding Amount:

$109M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wayne, Pennsylvania, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)palvellatx.com

Founders:

Wes Kaupinen

Number of Employees:

1-10

Last Funding Date:

2024-10-01

IPO Status:

Private

Industries: